Ad is loading...
FTXNX
Price
$49.20
Change
+$0.81 (+1.67%)
Updated
Nov 22 closing price
VISGX
Price
$83.69
Change
+$1.46 (+1.78%)
Updated
Nov 22 closing price
Ad is loading...

FTXNX vs VISGX

Header iconFTXNX vs VISGX Comparison
Open Charts FTXNX vs VISGXBanner chart's image
FullerThaler Behavioral Sm-Cp Gr I
Price$49.20
Change+$0.81 (+1.67%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Growth Index I
Price$83.69
Change+$1.46 (+1.78%)
VolumeN/A
CapitalizationN/A
FTXNX vs VISGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FTXNX vs. VISGX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTXNX is a Buy and VISGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VISGX has more cash in the bank: 35.8B vs. FTXNX (2.23B). VISGX pays higher dividends than FTXNX: VISGX (0.55) vs FTXNX (0.00). FTXNX was incepted earlier than VISGX: FTXNX (7 years) vs VISGX (27 years). FTXNX is a more actively managed with annual turnover of: 101.00 vs. VISGX (19.00). FTXNX has a lower initial minimum investment than VISGX: FTXNX (1000) vs VISGX (3000). FTXNX annual gain was more profitable for investors over the last year : 47.04 vs. VISGX (35.67). FTXNX return over 5 years is better than : 114.12 vs. VISGX (53.45).
FTXNXVISGXFTXNX / VISGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years27 years-
Gain YTD32.72121.206154%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets2.23B35.8B6%
Annual Yield % from dividends0.000.55-
Returns for 1 year47.0435.67132%
Returns for 3 years4.271.53279%
Returns for 5 years114.1253.45214%
Returns for 10 yearsN/A136.51-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZG79.264.26
+5.68%
Zillow Group
WOOF4.170.20
+5.04%
Petco Health and Wellness Company
PTGX41.651.00
+2.46%
Protagonist Therapeutics
MVO9.140.06
+0.66%
MV Oil Trust
HSDT0.43-0.02
-4.87%
Helius Medical Technologies